Journal of Molecular Medicine

, Volume 82, Issue 11, pp 775–780 | Cite as

DFNA54, a third locus for low-frequency hearing loss

  • Nicolas Gürtler
  • Yuil Kim
  • Anand Mhatre
  • Christoph Schlegel
  • Alfons Mathis
  • Anil K. LalwaniEmail author
Original Article


Nonsyndromic hereditary hearing impairment (NSHHI) is a highly heterogeneous disorder with more than 90 loci mapped, of which nearly one-half of the responsible genes are identified. In dominant NSSHI hearing loss is typically biased towards the high frequencies while low-frequency hearing loss is unusual. Only two NSHHI loci, DFNA1 and DFNA6/14/38, are associated with predominantly low- frequency loss. We mapped the loci harboring the gene responsible for autosomal dominant low-frequency hearing loss in a multigenerational family. The pedigree of a Swiss family with low-frequency hearing loss was established. Using genomic DNA, DFNA1 and DFNA6/14/38 were excluded by linkage analysis or by direct sequencing of the responsible gene. Genome-wide linkage analysis was performed using commercially available microsatellite markers. Two-point linkage analysis demonstrated linkage to chromosome 5q31, the locus for DFNA15, with a lod score of 6.32 at recombination fraction θ=0 for marker D5S436. Critical recombinations were seen at markers D5S1972 and D5S410. Sequencing of the corresponding gene POU4F3 yielded no pathogenic mutation segregating with the affected members. In addition to Wolfram syndrome gene 1 (DFNA6/14/38) and diaphanous (DFNA1) there is evidence for a third gene involved in low-frequency hearing loss located at DFNA15. Because of the differences in auditory phenotype and the absence of pathogenic mutation in the coding region of POU4F3 it is likely that there is a second gene in 5q31, designated DFNA54, associated with NSHHI.


Nonsyndromic hereditary hearing impairment Low-frequency hearing loss DFNA15 DFNA54 



Loss of heterozygosity


Nonsyndromic hereditary hearing impairment


Single-nucleotide polymorphism



We thank participating family members for their cooperation and the Molecular Genetics Facility at the University Hospital of Basel for technical support. This study was supported in part by grants from the Swiss National Science Foundation, the Novartis Foundation, and “Freiwillige Akademische Gesellschaft,” the latter both from Basel, Switzerland.


  1. 1.
    Lesperance MM, Hall JW 3rd, Bess FH, Fukushima K, Jain PK, Ploplis B, San Agustin TB, Skarka H, Smith RJ, Wills M et al (1995) A gene for autosomal dominant nonsyndromic hereditary hearing impairment maps to 4p16.3. Hum Mol Genet 4:1967–1972PubMedGoogle Scholar
  2. 2.
    Lynch ED, Lee MK, Morrow JE, Welcsh PL, Leon PE, King MC (1997) Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science 278:1315–1318CrossRefPubMedGoogle Scholar
  3. 3.
    Young TL, Ives E, Lynch E, Person R, Snook S, MacLaren L, Cator T, Griffin A, Fernandez B, Lee MK et al (2001) Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum Mol Genet 10:2509–2514CrossRefPubMedGoogle Scholar
  4. 4.
    Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K, DeWan AT, Erson AE, Flothmann K, Kunst HP, Kurnool P et al (2001) Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 10:2501–2508CrossRefPubMedGoogle Scholar
  5. 5.
    Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe Y, Shinoda K, Oka, Y (2001) WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 10:477–484CrossRefPubMedGoogle Scholar
  6. 6.
    Hofmann S, Philbrook C, Gerbitz KD, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 12:2003–2012CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang MKG, Urutia R, Kalinec F (2001) Dial proteins participate in the regulation of outer hair cell motility by acteylcholine. Presented at the Assoc Res Otolaryngol, St. Petersburg Beach, Fla.Google Scholar
  8. 8.
    Vahava O, Morell R, Lynch ED, Weiss S, Kagan ME, Ahituv N, Morrow JE, Lee MK, Skvorak AB, Morton CC et al (1998) Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 279:1950–1954CrossRefPubMedGoogle Scholar
  9. 9.
    Xia J, Deng H, Feng Y, Zhang H, Pan Q, Dai H, Long Z, Tang B, Chen Y, Zhang R et al (2002) A novel locus for autosomal dominant nonsyndromic hearing loss identified at 5q31.1–32 in a Chinese pedigree. J Hum Genet 47:635–640CrossRefPubMedGoogle Scholar
  10. 10.
    Kammen-Jolly K, Scholtz AW, Kreczy A, Gluckert R, Thalmann I, Thalmann R, Schrott-Fischer A (2002) OCP2 immunoreactivity in the human fetal cochlea at weeks 11:17:20, and 28, and the human adult cochlea. Hear Res 167:102–109CrossRefPubMedGoogle Scholar
  11. 11.
    Henzl MT, O’Neal J, Killick R, Thalmann I, Thalmann R (2001) OCP1, an F-box protein, co-localizes with OCP2/SKP1 in the cochlear epithelial gap junction region. Hear Res 157:100–111CrossRefPubMedGoogle Scholar
  12. 12.
    Usami S, Abe S, Weston MD, Shinkawa H, Van Camp G, Kimberling WJ (1999) Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 104:188–192CrossRefPubMedGoogle Scholar
  13. 13.
    Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, Green ED., Wilcox ER (1998) A mutation in PDS causes non-syndromic recessive deafness. Nat Genet 18:215–217CrossRefPubMedGoogle Scholar
  14. 14.
    Campbell C, Cucci RA, Prasad S, Green GE, Edeal JB, Galer CE, Karniski LP, Sheffield VC, Smith RJ (2001) Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 17:403–411CrossRefPubMedGoogle Scholar
  15. 15.
    Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, Thakkar SI, Hoogstraten-Miller SL, Kachar B, Wu DK, Green ED (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10:153–161CrossRefPubMedGoogle Scholar
  16. 16.
    Huang L, Gitschier J (1997) A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet 17:292–297PubMedGoogle Scholar
  17. 17.
    Dixon MJ, Gazzard J, Chaudhry SS, Sampson N, Schulte BA, Steel KP (1999) Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. Hum Mol Genet 8:1579–1584CrossRefPubMedGoogle Scholar
  18. 18.
    Wangemann P (2002) K+ cycling and the endocochlear potential. Hear Res 165:1–9CrossRefPubMedGoogle Scholar
  19. 19.
    Everett LA, Morsli H, Wu DK., Green ED (1999) Expression pattern of the mouse ortholog of the Pendred’s syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci USA 96:9727–9732CrossRefPubMedGoogle Scholar
  20. 20.
    Superti-Furga A, Rossi A, Steinmann B, Gitzelmann R (1996) A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations. Am J Med Genet 63:144–147CrossRefPubMedGoogle Scholar
  21. 21.
    Shafqat S, Velaz-Faircloth M, Henzi VA, Whitney KD, Yang-Feng TL, Seldin MF, Fremeau RT Jr (1995) Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes. Mol Pharmacol 48:219–229PubMedGoogle Scholar
  22. 22.
    Sagne C, Agulhon C, Ravassard P, Darmon M, Hamon M, El Mestikawy S, Gasnier B, Giros B (2001) Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci USA 98:7206–7211CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Nicolas Gürtler
    • 1
    • 2
  • Yuil Kim
    • 1
  • Anand Mhatre
    • 1
    • 3
  • Christoph Schlegel
    • 4
  • Alfons Mathis
    • 4
  • Anil K. Lalwani
    • 1
    • 3
    Email author
  1. 1.Laboratory of Molecular Otology, Epstein Laboratories, Department of Otolaryngology-Head and Neck SurgeryUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Hals-Nasen-Ohren-KlinikKantonsspitalAarauSwitzerland
  3. 3.Department of OtolaryngologyNYU School of MedicineNew YorkUSA
  4. 4.Hals-Nasen-Ohren-KlinikKantonsspitalLucerneSwitzerland

Personalised recommendations